CNS PHARMACEUTICALS INC
Q1 2026 13F Holders
Symbol
CNSP
CUSIP
18978H508
Type
Equity
Class
COM
Num filings
11
Total reported value, excl. options
$349 k
Compare 2026 Q1 to
2026 Q2
2025 Q4
2025 Q3
2025 Q2
Manager
Report Date
Value ($000)
Shares
Option Type